☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
~$2.49B
Celltrion's CT-P59 (regdanvimab) Receives CHMP's Positive Opinion for the Treatment of COVID-19
November 12, 2021
Coloplast to Acquire Atos Medical for ~$2.49B
November 10, 2021
Load more...
Back to Home
